EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Colistin Sensitivity in Panresistant Enterobacterales, Acinetobacter, and Pseudomonas Species by Broth Microdilusion Method

Pinar Samlioglu, Guliz Dogan

International Journal of Medical Discoveries · 2025

DOI: 10.64220/ijmd.v1i2.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Discoveries, 2025. Verfasst von Pinar Samlioglu und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colistin, discovered in the 1940s, was initially used as a broad-spectrum antibiotic against gram-negative bacteria. Due to its significant nephrotoxic and neurotoxic effects, its systemic use declined in the 1970s. However, colistin has re-emerged as a critical therapeutic option with the increasing prevalence of multidrug-resistant pathogens, particularly those producing carbapenemases and extended-spectrum beta-lactamases.

Objective

This study aimed to evaluate colistin susceptibility in panresistant Enterobacterales, Acinetobacter, and Pseudomonas species using the broth microdilution method.

Methods

A total of 124 non-duplicate clinical isolates were collected from March 2021 to April 2023, including Klebsiella pneumoniae (52%), Acinetobacter baumannii (35%), Escherichia coli (6%), Pseudomonas aeruginosa (6%), Acinetobacter jejunii (2%), and Klebsiella oxytoca (1%). Patient samples were obtained from various hospital units. Colistin susceptibility testing was performed using the CLSI-EUCAST 2016 guidelines, following the broth microdilution method. MIC values ≤2 µg/ml were considered susceptible, and ≥4 µg/ml resistant.

Results

Out of 124 isolates, 77 (62.1%) were colistin-susceptible, and 47 (37.9%) were resistant. Resistance rates among key species were: K. pneumoniae (39.1%), A. baumannii (30.2%), E. coli (28.6%), and P. aeruginosa (85.7%). Resistant isolates were identified in urine (8.1%), blood (14.5%), and respiratory samples (4.8%).

Conclusion

Colistin remains a valuable therapeutic agent against multidrug-resistant gram-negative bacteria. Routine susceptibility testing is essential to guide appropriate use and prevent the emergence of further resistance.

Zitieren

APA

Samlioglu, P., & Dogan, G. (2025). Evaluation of Colistin Sensitivity in Panresistant Enterobacterales, Acinetobacter, and Pseudomonas Species by Broth Microdilusion Method. International Journal of Medical Discoveries. https://doi.org/10.64220/ijmd.v1i2.006

Vancouver

Samlioglu P, Dogan G. Evaluation of Colistin Sensitivity in Panresistant Enterobacterales, Acinetobacter, and Pseudomonas Species by Broth Microdilusion Method. International Journal of Medical Discoveries. 2025. doi:10.64220/ijmd.v1i2.006

BibTeX
@article{Samlioglu2025,
  author = {Samlioglu, Pinar and Dogan, Guliz},
  title = {Evaluation of Colistin Sensitivity in Panresistant Enterobacterales, Acinetobacter, and Pseudomonas Species by Broth Microdilusion Method},
  journal = {International Journal of Medical Discoveries},
  year = {2025},
  doi = {10.64220/ijmd.v1i2.006}
}
Kostenlos starten →